Cravatex: Unaudited Financial Results for the quarter and half year ended 30th September, 2026 are attached
Cravatex (CRAVATEX) filed a disclosure titled "Unaudited Financial Results for the quarter and half year ended 30th September, 2026 are attached". The company is valued at about ₹80.5 crore.
What happened
Cravatex (CRAVATEX) filed a disclosure with the exchanges on 3 November 2026 at 04:51 PM titled "Unaudited Financial Results for the quarter and half year ended 30th September, 2026 are attached".
Company snapshot
Cravatex is a micro-cap company, with a market value of about ₹80.5 crore.
The stock last traded at ₹311.5, against a 52-week range of ₹263–₹410 (24.0% below the high).
Before this filing the shares had moved −10.2% over the month. Average daily turnover over the last 20 sessions was about ₹0.02 crore.
Promoters held 75.00% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1 | 0.4 | 1.71 |
| Q2 FY26 | 3 | 0.3 | 1.28 |
| Q3 FY26 | 3 | 2.6 | 10.2 |
| Q4 FY26 | — | 2.1 | 8.27 |
| Q1 FY27 | 1 | 0.4 | 1.59 |
What history shows
BCEIE has no earlier results filing from this company on record since May 2026.
Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.